William Young

William Young

Direttore/Membro del Consiglio presso AUTOLUS THERAPEUTICS PLC

Patrimonio netto: 1 M $ in data 31/07/2026

81 anni
Health Technology
Finance
Commercial Services

Profilo

William D.
Young
is currently Director at Raven Biotechnologies, Inc., Director at SFJ Pharmaceuticals, Inc. since 2010, Independent Director at Praxis Precision Medicines, Inc. since 2016, Non-Executive Director at Autolus Therapeutics Plc since 2021, Member of the National Academy of Engineering, Senior Advisor at Blackstone, Inc. since 2009, and Trustee at Montage Health.
Formerly, Mr. Young was Chairman & Chief Executive Officer at Monogram Biosciences, Inc. from 2000 to 2009, Chairman at Biogen, Inc. in 2014, Chairman at AGY Therapeutics, Inc., Chairman at TYRX, Inc., Chairman at Annexon, Inc. from 2017 to 2021, Chairman-Emeritus at The Bay Area Bioscience Association, Chairman at NS Wind Down Co., Inc. from 2010 to 2024, Independent Director at Vertex Pharmaceuticals, Inc. from 2015 to 2020, Director at Human Genome Sciences, Inc. from 2003 to 2006, Independent Non-Executive Director at BioMarin Pharmaceutical, Inc. from 2010 to 2015, Director at VaxGen, Inc., Director at Receptor BioLogix, Inc., Director at IDEC Pharmaceuticals Corp., Independent Director at Innoviva, Inc. from 2011 to 2014, Director at Biogen Idec New Ventures, Inc. from 1997 to 2010, Director at Biogen Idec, Inc. (North Carolina) from 1997 to 2014, Independent Director at Ariosa Diagnostics, Inc., Director at Biomarine, Inc., Lead Independent Director at Theravance Biopharma, Inc. from 2013 to 2023, Chief Operating Officer at Genentech, Inc. from 1997 to 1999, Member-Supervisory Board at DHB Verwaltungs AG, Venture Partner at Clarus Ventures LLC from 2010 to 2018, and Senior Advisor at Blackstone Life Sciences Advisors LLC.
Education includes an MBA from Indiana University conferred in 1971 and an undergraduate degree from Purdue University conferred in 1966.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
10/06/2026 3.269 ( 0,01% ) 1 M $ 31/07/2026
29/06/2026 0 ( -.--% ) - $ 31/07/2026

Posizioni attive di William Young

SocietàPosizioneInizio
PRAXIS PRECISION MEDICINES, INC. Direttore/Membro del Consiglio 01/12/2016
BLACKSTONE INC. Consulente / Consigliere 01/01/2009
AUTOLUS THERAPEUTICS PLC Direttore/Membro del Consiglio 15/11/2021
Direttore/Membro del Consiglio 01/01/2010
Direttore/Membro del Consiglio -
Corporate Officer/Principal -
Direttore/Membro del Consiglio -

Precedenti posizioni note di William Young

SocietàPosizioneFine
NS WIND DOWN CO., INC. Presidente 26/06/2024
THERAVANCE BIOPHARMA, INC. Direttore/Membro del Consiglio 01/02/2023
░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di William Young

Formazione di William Young

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

74

Relazioni di 1° grado

32

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Electronic Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Consumer Services

Health Technology

Finance

Finance

Commercial Services

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

  1. Mercati
  2. Insiders
  3. William Young